
OpenEvidence, an AI tool used by American doctors, is now being offered in countries with limited access to medical literature. Reuters reported that the company is working with Anthropic to give clinicians in low- and middle-income countries free acce…

From the day I started Heidi, the ambition was always bigger than writing doctor’s notes. Dr Thomas Kelly said that on Tuesday, as the company he cofounded announced US$340m of new funding. The money arrives in two parts. In its announcement, Heidi sai…

The Paris-based company Biolevate, which develops AI automation for use in regulated life sciences, has raised €30m in its Series A funding and has opened an office in Boston. Orange Ventures and RAISE France co-led the fundraising exercise, with the c…

“For decades, small businesses have been sold the leftovers of the health insurance market,” said Nikhil Aggarwal, chief executive and co-founder of Corridor. His company launched its AI benefits brokerage on Monday with $25m. Its plan is to change tha…

“Joining forces with Anthropic will supercharge our R&D organisation and help us on our mission to bring new, transformative health solutions to people living with chronic diseases,” said Mike Doustdar, president and chief executive of Novo. The Da…

ByteDance closed a $290M funding round for Anew Labs, its newly spun-off AI drug discovery unit, at a $1.5B valuation, Reuters reports, citing two sources familiar with the matter. Moreover, the company that owns TikTok will retain 56% of the business …

Stockholm-based Tandem Health has raised $100m in a Series B round led by the Scaleup Europe Fund, which EQT manages. The company announced the round on 14 September. Existing investors Kinnevik, Northzone, Amino Collective, and Visionaries also took p…

The math behind the data storage problem is brutal. The world creates more information every year than it can afford to keep. Most of it is cold. It is almost never read, yet it cannot be deleted, so it accumulates on tape and disk that degrade, draw p…